Loading viewer...
conference
Format: PDF conference
Telix Pharmaceuticals presented its precision oncology radiopharmaceutical portfolio at the JP Morgan Virtual Healthcare Conference in January 2022. The company highlighted FDA approval for Illuccix (TLX591-CDx) for prostate cancer imaging, alongside its extensive global distribution network reaching 80 countries and active clinical programs across 8 indications.
conference
20 Pages
Electro Scientific Industries
NESR 2020 Barclays CEO Energy Conference Presentation
conferenceconference
16 Pages
National Energy Services Reunited Corp.
CSL 2016 Communacopia Conference - Communications REIT Strategy
conferenceconference
22 Pages
Consolidated Tomoka Land Co